Literature DB >> 6426699

Adrenal medullary implants in the dopamine-denervated rat striatum. II. Acute behavior as a function of graft amount and location and its modulation by neuroleptics.

M Herrera-Marschitz, I Strömberg, D Olsson, U Ungerstedt, L Olson.   

Abstract

Rotational behavior was studied in rats with unilateral 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine system, following intrastriatal grafting of pieces of the adrenal medulla or nervus opticus. The rats were placed in rotometers immediately after the operation. No rotational response was seen in animals implanted with nervus opticus. Rats that received one whole adrenal medullary gland, divided into 4 pieces, showed a strong rotational response with a peak after 100 min and a duration of 400 min. Adrenal medulla-induced rotations were dose-dependent: when rats were grafted with 2, 4 or 8 pieces (where 4 pieces equals one whole adrenal medulla) into 2 sites, 2 pieces induced about half the amount of rotation as 4 pieces, while 8 pieces caused a higher total number of rotations with the 100 min peak approximately doubled compared with rats that had received 4 pieces. The coordinates for the implantation site were also important determinants of the rotational behavior: 4 implantation sites were tested and it was shown that the most central site in the caudate caused the highest total amount of rotations. The rotational behavior could be blocked in a dose-dependent manner by the dopamine-receptor antagonists haloperidol and cis-flupenthixol given immediately after grafting. It is concluded that implantation of chromaffin tissue from the adrenal medulla into the unilaterally 6-hydroxydopamine-denervated striatum causes highly reproducible acute rotational responses that vary with the amount and location of the implanted tissue and that can be blocked by neuroleptics. Thus the experiments permit screening of areas within neostriatum that produce different rotational responses to chromaffin implants.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426699     DOI: 10.1016/0006-8993(84)90542-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease.

Authors:  J A Wolff; L J Fisher; L Xu; H A Jinnah; P J Langlais; P M Iuvone; K L O'Malley; M B Rosenberg; S Shimohama; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Fate of intraocular chromaffin cell suspensions: role of initial nerve growth factor support.

Authors:  I Strömberg; A Hultgårdh-Nilsson; U Hedin; T Ebendal
Journal:  Cell Tissue Res       Date:  1988       Impact factor: 5.249

3.  Neurocircuitry of the basal ganglia studied by monitoring neurotransmitter release. Effects of intracerebral and perinatal asphyctic lesions.

Authors:  M Herrera-Marschitz; C F Loidl; Z B You; K Andersson; R Silveira; W T O'Connor; M Goiny
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

4.  Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior.

Authors:  I Strömberg; M Herrera-Marschitz; U Ungerstedt; T Ebendal; L Olson
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

5.  Nerve fiber production by intraocular adrenal medullary grafts: stimulation by nerve growth factor or sympathetic denervation of the host iris.

Authors:  I Strömberg; T Ebendal; A Seiger; L Olson
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

6.  Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats.

Authors:  A McRae; E A Ling; S Hjorth; A Dahlström; D Mason; T Tice
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

7.  Properties of PC12 pheochromocytoma cells transplanted to the adult rat brain.

Authors:  W J Freed; U Patel-Vaidya; H M Geller
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

8.  Defining the unknowns for cell therapies in Parkinson's disease.

Authors:  Emma L Lane; Mariah J Lelos
Journal:  Dis Model Mech       Date:  2022-09-27       Impact factor: 5.732

Review 9.  Nerve growth factor: from the early discoveries to the potential clinical use.

Authors:  Luigi Aloe; Maria Luisa Rocco; Patrizia Bianchi; Luigi Manni
Journal:  J Transl Med       Date:  2012-11-29       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.